1 Introduction Due to its rapid spread and rising mortality rate, the pandemic brought on by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as Corona Virus Disease 2019 (COVID-19), has had a significant influence on the entire world
Overactivation, use during late-stage disease characterized by NAD + depletion, or lack of tissue specificity may result in adverse effects, including oxidative damage, energy imbalance, or cell death
So, who has the Goldilocks of oral GLP-1 agonists
Open Medicine, 18 (1), Article 20230692
In addition, GLP-1 medications vary in dosage strength and how quickly doses are escalated